The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

If you don't like the high prices that can come with popular weight-loss drugs like Ozempic-or the needle pokes they ...